Business Description
AIM ImmunoTech Inc. is a US-based medical research company working to develop treatments for cancer, viral infections, and immune system disorders. Its two main products are Ampligen, used to treat chronic fatigue syndrome, and Alferon N Injection, which targets genital warts. The company is also exploring Ampligen as a potential therapy for a wide range of cancers and conditions including HIV, Hepatitis B, and COVID-19. Founded in 1966 and based in Ocala, Florida, the company operated under the name Hemispherx Biopharma Inc. before rebranding in 2019.
